3′-O-(3-Chloropivaloyl)quercetin, α-glucosidase inhibitor with multi-targeted therapeutic potential in relation to diabetic complications

Chemical Papers

Volumn 70, Issue 11, 2016, Pages 1439-1444

  Soltesova Prnova, Marta ^a   Milackova, Ivana ^b   Stefek, Milan ^a  

^a INSTITUTE OF EXPERIMENTAL PHARMACOLOGY AND TOXICOLOGY   (Slovakia)

^b Faculty of Natural Sciences   (Slovakia)

Author keywords

3 O (3 chloropivaloyl)quercetin; aldose reductase inhibitor; antioxidant; diabetic complications; glucosidase inhibitor

Indexed keywords

EID: 84983268386     PISSN: 03666352     EISSN: 13369075     Source Type: Journal    
DOI: 10.1515/chempap-2016-0078     Document Type: Article

References (38)

1. Alexiou, P., Pegklidou, K., Chatzopoulou, M., Nicolaou, I., & Demopoulos, V. J. (2009). Aldose reductase enzyme and its implication to major health problems of the 21st century. Current Medicinal Chemistry, 16, 734-752. DOI: 10.2174/092986709787458362.
2. Amic, D., Davidovic-Amic, D., Beslo, D., Rastija, V., Lucic, B., & Trinajstic, N. (2007). SAR and QSAR of the antioxidant activity of flavonoids. Current Medicinal Chemistry, 14, 827-845. DOI: 10.2174/092986707780090954.
3. Blois, M. S. (1958). Antioxidant determinations by the use of a stable free radical. Nature, 181, 1199-1200. DOI: 10.1038/1811199a0.
4. Boots, A. W., Haenen, G. R. M. M., & Bast, A. (2008). Health effects of quercetin: From antioxidant to nuhaceutical. European Journal of Pharmacology, 585, 325-337. DOI: 10.1016/j.ejphar.2008.03.008.
5. Bors, W., & Michel, C. (2002). Chemistry of the antioxidant effect of polyphenols. Annals of the New York Academy of Sciences, 957, 57-69. DOI: 10.1111/j.1749-6632.2002.tb02905.x.
6. Butković, V., Klasinc, L., & Bors, W. (2004). Kinetic study of flavonoid reactions with stable radicals. Journal of Agricultural and Food Chemistry, 52, 2816-2820. DOI: 10.1021/jf049880h.
7. Cao, H., & Chen, X. Q. (2012). Structures required of flavonoids for inhibiting digestive enzymes. Anti-Cancer Agents in Medicinal Chemistry, 12, 929-939. DOI: 10.2174/187152012 802650110.
8. Chatzopoulou, M., Alexiou, P., Kotsampasakou, E., & Demopoulos, V. J. (2012). Novel aldose reductase inhibitors: A patent survey (2006-present). Expert Opinion on Therapeutic Patents, 11, 1303-1323. DOI: 10.1517/13543776.2012.72 6615.
9. Chatzopoulou, M., Pegklidou, K., Papastavrou, N., & Demopoulos, V. J. (2013). Development of aldose reductase inhibitors for the treatment of inflammatory disorders. Expert Opinion on Drug Discovery, 8, 1365-1380. DOI: 10.1517/17460441.2013.843524.
10. Chen, J., Mangelinckx, S., Adams, A., Wang, Z. T., Li, W. L., & De Kimpe, N. (2015). Natural flavonoids as potential herbal medication for the treatment of diabetes mellitus and its complications. Natural Product Communications, 10, 187-200.
11. Goupy, P., Dufour, C., Loonis, M., & Dangles, O. (2003). Quantitative kinetic analysis of hydrogen transfer reactions from dietary polyphenols to the DPPH radical. Journal of Agricultural and Food Chemistry, 51, 615-622. DOI: 10.1021/jf025938l.
12. Hakamata, W., Kurihara, M., Okuda, H., Nishio, T., & Oku, T. (2009). Design and screening strategies for α- glucosidase inhibitors based on enzymological information. Current Topics in Medicinal Chemistry, 9, 3-12. DOI: 10.2174/156802609787354306.
13. Hayman, S., & Kinoshita, J. H. (1965). Isolation and properties of lens aldose reductase. The Journal of Biological Chemistry, 240, 877-882.
14. Kelsey, N. A., Wilkins, H. M., & Linseman, D. A. (2010). Nutraceutical antioxidants as novel neuroprotective agents. Molecules, 15, 7792-7814. DOI: 10.3390/molecules15117792.
15. Kuniaková, M., Mrvová, N., Knezl, V., & Račková, Ľ. (2015). Effect of novel quercetin pivaloyl ester on functions of adult rat microglia. Biologia, 70, 690-702. DOI: 10.1515/biolog-2015-0082.
16. Kwon, Y. I., Vattem, D. A., & Shetty, K. (2006). Evaluation of clonal herbs of Lamiaceae species for management of diabetes and hypertension. Asia Pacific Journal of Clinical Nutrition, 15, 107-118.
17. Majumdar, S., & Srirangam, R. (2010). Potential of the bioflavonoids in the prevention/treatment of ocular disorders. Journal of Pharmacy and Pharmacology, 62, 951-965. DOI: 10.1211/jpp.62.08.0001.
18. Matsuda, H., Morikawa, T., Toguchida, I., & Yoshikawa, M. (2002). Structural requirements of flavonoids and related compounds for aldose reductase inhibitory activity. Chemical & Pharmaceutical Bulletin, 50, 788-795. DOI: 10.1248/cpb.50.788.
19. Matsuda, H., Wang, T., Managi, H., & Yoshikawa, M. (2003). Structural requirements of flavonoids for inhibition of protein glycation and radical scavenging activities. Bioorganic & Medicinal Chemistry, 11, 5317-5323. DOI: 10.1016/j.bmc. 2003.09.045.
20. Miyamoto, S. (2002). Recent advances in aldose reductase inhibitors: Potential agents for the treatment of diabetic complications. Expert Opinion on Therapeutic Patents, 12, 621-631. DOI: 10.1517/13543776.12.5.621.
21. Milackova, I., Kovacikova, L., Veverka, M., Gallovic, E., & Stefek, M. (2013). Screening for antiradical efficiency of 21 semisynthetic derivatives of quercetin in a DPPH assay. Interdisciplinary Toxicology, 6, 13-17. DOI: 10.2478/intox-2013-0003.
22. Milackova, I., Soltesova Prnova, M., Majekova, M., Sotnikova, R., Stasko, M., Kovacikova, L., Banerjee, S., Veverka, M., & Stefek, M. (2015). 2-Chloro-1,4-naphthoquinone derivative of quercetin as an inhibitor of aldose reductase and anti-inflammatory agent. Journal of Enzyme Inhibition and Medicinal Chemistry, 30, 107-113. DOI: 10.3109/14756366. 2014.892935.
23. Mrvová, N., Škandík, M., Kuniaková, M., & Račková, L. (2015). Modulation of BV-2 microglia functions by novel quercetin pivaloyl ester. Neurochemistry International, 90, 246-254. DOI: 10.1016/j.neuint.2015.09.005.
24. Mylari, B. L., Armento, S. J., Beebe, D. A., Conn, E. L., Coutcher, J. B., Dina, M. S., O'Gorman, M. T., Linhares, M. C., Martin, W. H., Oates, P. J., Tess, D. A., Withbroe, G. J., & Zembrowski, W. J. (2003). A highly selective, nonhydantoin, non-carboxylic acid inhibitor of aldose reductase with potent oral activity in diabetic rat models: 6-(5-Chloro-3-methylbenzofuran-2-sulfonyl)-2-H-pyridazin-3-one. Journal of Medicinal Chemistry, 46, 2283-2286. DOI: 10.1021/jm034065z.
25. Nijveldt, R. J., van Nood, E., van Hoorn, D. E. C., Boelens, P. G., van Norren, K., & van Leeuwen, P. A. M. (2001). Flavonoids: A review of probable mechanisms of action and potential applications. American Journal of Clinical Nutrition, 74, 418-425.
26. Park, H. S., Hwang, K. Y., Oh, K. H., Kim, Y. H., Lee, J. Y., & Kim, K. (2008). Discovery of novel alpha-glucosidase inhibitors based on the virtual screening with the homologymodeled protein structure. Bioorganic & Medicinal Chemistry, 16, 284-292. DOI: 10.1016/j.bmc.2007.09.036.
27. Ratty, A. K., Sunamoto, J., & Das, N. P. (1988). Interaction of flavonoids with 1,1-diphenyl-2-picrylhydrazyl free radical, liposomal membranes and soybean lipoxygenase-1. Biochemical Pharmacology, 37, 989-996. DOI: 10.1016/0006-2952(88)90499-6.
28. Singh, R., Kaur, N., Kishore, L., & Gupta, G. K. (2013). Management of diabetic complications: A chemical constituents based approach. Journal of Ethnopharmacology, 150, 51-70. DOI: 10.1016/j.jep.2013.08.051.
29. Srivastava, S. K., Ramana, K. V., & Bhatnagar, A. (2005). Role of aldose reductase and oxidative damage in diabetes and the consequent potential for therapeutic options. Endocrine Reviews, 26, 380-392. DOI: 10.1210/er.2004-0028.
30. Stefek, M., Snirc, V., Djoubissie, P. O., Majekova, M., Demopoulos, V., Račková, Ľ., Bezakova, Z., Karasu, C., Carbone, V., & El-Kabbani, O. (2008). Carboxymethylated pyridoindole antioxidants as aldose reductase inhibitors: Synthesis, activity, partitioning and molecular modelling. Bioorganic & Medicinal Chemistry, 16, 4908-4920. DOI: 10.1016/j.bmc.2008.03.039.
31. Stefek, M. (2011). Natural flavonoids as potential multifunctional agents in prevention of diabetic cataract. Interdisciplinary Toxicology, 4, 69-77. DOI: 10.2478/v10102-011-0013-y.
32. Stefek, M., Tsantili-Kakoulidou, A., Milackova, I., Juskova, M., Snirc, V., & Triantos, N. (2011). (2-Benzyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indol-8-yl)-acetic acid: An aldose reductase inhibitor and antioxidant of zwitterionic nature. Bioorganic & Medicinal Chemistry, 19, 7181-7185. DOI: 10.1016/j.bmc.2011.09.053.
33. Veverka, M., Gallovič, J., Švajdlenka, E., Veverková, E., Prónayová, N., Miláčková, I., & Štefek, M. (2013). Novel quercetin derivatives: Synthesis and screening for antioxidant activity and aldose reductase inhibition. Chemical Papers, 67, 76-83. DOI: 10.2478/s11696-012-0240-5.
34. Villaño, D., Fernández-Pachón, M. S., Moyá, M. L., Troncoso, A. M., & García-Parrilla, M. C. (2007). Radical scavenging ability of polyphenolic compounds towards DPPH free radical. Talanta, 71, 230-235. DOI: 10.1016/j.talanta.2006.03. 050.
35. Williams, R. J., Spencer, J. P. E., & Rice-Evans, C. (2004). Flavonoids: Antioxidants or signalling molecules? Free Radical Biology & Medicine, 36, 838-849. DOI: 10.1016/j. freeradbiomed.2004.01.001.
36. Xiao, J. B., Kai, G. Y., Yamamoto, K., & Chen, X. Q. (2013). Advance in dietary polyphenols as α-glucosidases inhibitors: A review on structure-activity relationship aspect. Critical Reviews in Food Science and Nutrition, 53, 818-836. DOI: 10.1080/10408398.2011.561379.
37. Yabe-Nishimura, C. (1998). Aldose reductase in glucose toxicity: A potential target for the prevention of diabetic complications. Pharmacological Reviews, 1, 50, 21-33.
38. Žižková, P., Blaškovič, D., Májeková, M., Švorc, L., Račková, L., Ratkovská, Ľ., Veverka, M., & Horáková, Ľ. (2014). Novel quercetin derivatives in treatment of peroxynitrite-oxidized SERCA1. Molecular and Cellular Biochemistry, 386, 1-14. DOI: 10.1007/s11010-013-1839-8.